These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29291782)

  • 21. 3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Zou LQ; Zhang BL; Chang Q; Zhu FP; Li YY; Wei YQ; Guan YS
    World J Gastroenterol; 2014 Dec; 20(45):17227-34. PubMed ID: 25493039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma.
    White JA; Redden DT; Bryant MK; Dorn D; Saddekni S; Abdel Aal AK; Zarzour J; Bolus D; Smith JK; Gray S; Eckhoff DE; DuBay DA
    HPB (Oxford); 2014 Dec; 16(12):1095-101. PubMed ID: 25158123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
    Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
    J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample.
    Mishra A; Otgonsuren M; Venkatesan C; Afendy M; Erario M; Younossi ZM
    Liver Int; 2013 Sep; 33(8):1281-6. PubMed ID: 23710596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score.
    Op den Winkel M; Nagel D; Op den Winkel P; Trojan J; Paprottka PM; Steib CJ; Schmidt L; Göller M; Stieber P; Göhring P; Herbst A; Rentsch M; De Toni EN; Göke B; Gerbes AL; Kolligs FT
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):44-53. PubMed ID: 29076939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hepatocellular carcinoma in elderly patients.
    Kang SD; Kim JW; Jwa YJ; Choi YH; Song TJ; Bae WK; Kim NH; Kim KA; Lee JS
    Hepatogastroenterology; 2014 Oct; 61(135):2001-8. PubMed ID: 25713902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma.
    Song DS; Nam SW; Bae SH; Kim JD; Jang JW; Song MJ; Lee SW; Kim HY; Lee YJ; Chun HJ; You YK; Choi JY; Yoon SK
    World J Gastroenterol; 2015 Feb; 21(8):2395-404. PubMed ID: 25741147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
    World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhu ZX; Wang XX; Yuan KF; Huang JW; Zeng Y
    HPB (Oxford); 2018 Sep; 20(9):795-802. PubMed ID: 29779970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma.
    Zhu SL; Zhong JH; Ke Y; Ma L; You XM; Li LQ
    World J Gastroenterol; 2015 Aug; 21(32):9630-7. PubMed ID: 26327771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
    Zhang Y; Fan W; Wang Y; Lu L; Fu S; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2015 Dec; 20(12):1417-24. PubMed ID: 26446238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience from a real-life cohort: outcome of 606 patients with hepatocellular carcinoma following transarterial chemoembolization.
    Kirstein MM; Schweitzer N; Ay N; Boeck C; Lappas K; Hinrichs JB; Voigtländer T; Wacker F; Manns MP; Rodt T; Vogel A
    Scand J Gastroenterol; 2017 Jan; 52(1):116-124. PubMed ID: 27598949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
    Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
    World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of Transarterial Chemoembolization (TACE) and Radiofrequency Ablation (RFA) vs. Surgical Resection (SR) on Survival Outcome of Early Hepatocellular Carcinoma: A Meta-Analysis.
    Guo W; He X; Li Z; Li Y
    Hepatogastroenterology; 2015 May; 62(139):710-4. PubMed ID: 26897959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.
    Hsu CY; Huang YH; Su CW; Lin HC; Chiang JH; Lee PC; Lee FY; Huo TI; Lee SD
    Liver Int; 2010 Jan; 30(1):77-84. PubMed ID: 19818004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and meta-analysis of hepatic resection versus transarterial chemoembolization for solitary large hepatocellular carcinoma.
    Stevens CL; Awad A; Abbas SM; Watters DAK
    HPB (Oxford); 2017 Aug; 19(8):653-658. PubMed ID: 28427829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
    Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
    J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
    Xing M; Webber G; Prajapati HJ; Chen Z; El-Rayes B; Spivey JR; Pillai AA; Kim HS
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1167-74. PubMed ID: 25675849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.